Wedgewood Pharmacy 因潜在效价问题召回有效期内部分复方兽药
Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues
Wedgewood Pharmacy 于 2026 年 10 月 21 日宣布召回有效期内部分复方兽药,原因是其实验室部分分析检测数据可靠性不一致,可能导致产品效价偏低或偏高。受影响产品于 2026 年 2 月 18 日至 10 月 6 日发往美国各地兽医诊所、药房等客户,召回在供应商与客户层面进行。公司称已收到 98 起投诉,其中 7 起为严重投诉,相关产品不用于食用动物。
公告说明了复方兽药召回的原因、发货时间范围与投诉数量,可供了解效价异常情形下召回范围如何界定。
COMPANY ANNOUNCEMENT
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.
Summary
- Company Announcement Date:
- October 21, 2026
- FDA Publish Date:
- October 21, 2026
- Product Type:
- Animal & Veterinary
Drugs - Reason for Announcement:
-
Recall Reason Description
Potential Potency Issues
- Company Name:
- Wedgewood Pharmacy, LLC.
- Brand Name:
-
Brand Name(s)
No Brand Name
- Product Description:
-
Product Description
Compounded veterinary medications
Company Announcement
SWEDESBORO, N.J., (October 21, 2026) - Wedgewood Pharmacy LLC ("Wedgewood") is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resulting in subpotent and/or superpotent products. The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S. The issue was discovered through Wedgewood’s own quality processes. A complete list of affected products (including powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear solutions and suspensions, topical sprays, and gels), lot numbers, and expiration dates are available at www.wedgewood.com/recall-lookup/. The products involved are intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. They are not intended for use in food-producing animals.
Hazard Statement: The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose. To date, Wedgewood has received 98 complaints, of which 7 are serious. Customers should contact their veterinarians if they have medical concerns.
For customers: Wedgewood has engaged Sedgwick to support the coordination of this recall. Sedgwick is notifying affected customers via email and mail and is arranging a refund or, where possible, replacement of recalled products. Animal owners who have received affected product should stop use, retain the product, and contact Wedgewood’s recall services by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET.
For businesses: Veterinary practices, pharmacies, and other customers should immediately examine their inventory, quarantine any affected product and contact Wedgewood’s recall services by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET. Veterinary practices or pharmacies who have further dispensed affected product should identify and notify their customers of the recall.
For clinical alternatives: Wedgewood is working to help customers, veterinarians, and pet owners maintain continuity of care, including identifying clinically appropriate alternatives where available. To identify alternative treatment options, customers can contact Sedgwick by phone at 866-562-5931 Monday through Friday 8am – 9pm ET and Saturday 9am to 5pm ET. Sedgwick will refer any clinical questions to Wedgewood’s care team.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA at 1888-FDA-VETS or online at http://www.FDA.gov/reportanimalae.
Company Contact Information
- Consumers:
- Sedgwick
- 866-562-5931
来源:FDA 官方药品与生物制品信息 · fda.gov